Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Colorectal Cancer|Breast Cancer|Pancreas Cancer|Ovarian Cancer|Small-cell Lung Cancer|Gastric Cancer|Head and Neck Cancer
Interventions: DRUG: SNB-101
Sponsor: SN BioScience